Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 May;68(2):225–232.

Immunological aspects of chronic active hepatitis.

S Vento 1, A L Eddleston 1
PMCID: PMC1542717  PMID: 3308211

Full text

PDF
225

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballieux R. E., Heijnen C. J., Uytdehaag F., Zegers B. J. Regulation of B cell activity in man: role of T cells. Immunol Rev. 1979;45:3–39. doi: 10.1111/j.1600-065x.1979.tb00271.x. [DOI] [PubMed] [Google Scholar]
  2. Bardadin K. A., Desmet V. J. Interdigitating and dendritic reticulum cells in chronic active hepatitis. Histopathology. 1984 Jul;8(4):657–667. doi: 10.1111/j.1365-2559.1984.tb02378.x. [DOI] [PubMed] [Google Scholar]
  3. Bartholomaeus W. N., O'Donoghue H., Reed W. D. Thymus-dependence of autoantibody responses to liver specific lipoprotein in the mouse. Clin Exp Immunol. 1984 Mar;55(3):541–545. [PMC free article] [PubMed] [Google Scholar]
  4. Cochrane A. M., Moussouros A., Thomsom A. D., Eddleston A. L., Wiiliams R. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet. 1976 Feb 28;1(7957):441–444. doi: 10.1016/s0140-6736(76)91472-0. [DOI] [PubMed] [Google Scholar]
  5. Dusheiko G. M., Hoofnagle J. H., Cooksley W. G., James S. P., Jones E. A. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. J Clin Invest. 1983 May;71(5):1104–1113. doi: 10.1172/JCI110860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eddleston A. L., Williams R. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet. 1974 Dec 28;2(7896):1543–1545. doi: 10.1016/s0140-6736(74)90287-6. [DOI] [PubMed] [Google Scholar]
  7. Eggink H. F., Houthoff H. J., Huitema S., Gips C. H., Poppema S. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. Clin Exp Immunol. 1982 Oct;50(1):17–24. [PMC free article] [PubMed] [Google Scholar]
  8. Gerber M. J., Phuangsab A., Vittal S. B., Dourdourekas D., Steigmann F., Clowdus B. F. Cell-mediated immune response to hepatitis B antigen in patients with liver disease. Am J Dig Dis. 1974 Jul;19(7):637–643. doi: 10.1007/BF01073019. [DOI] [PubMed] [Google Scholar]
  9. Gonzales C., Cochrane A. M., Eddleston A. L., Williams R. Mechanisms responsible for antibody-dependent, cell-mediated cytotoxicity to isolated hepatocytes in chronic active hepatitis. Gut. 1979 May;20(5):385–388. doi: 10.1136/gut.20.5.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Heijnen C. J., Pot K. H., Ballieux R. E. Characterization of human T suppressor-inducer, -precursor and -effector lymphocytes in the antigen-specific plaque-forming cell response. Eur J Immunol. 1982 Oct;12(10):860–866. doi: 10.1002/eji.1830121012. [DOI] [PubMed] [Google Scholar]
  11. Heijnen C. J., Uytdehaag F., Pot C. H., Ballieux R. E. Feedback inhibition by human primed T-helper cells. Nature. 1979 Aug 16;280(5723):589–591. doi: 10.1038/280589a0. [DOI] [PubMed] [Google Scholar]
  12. Hopf U., Meyer zum Büschenfelde K. H., Arnold W. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis. N Engl J Med. 1976 Mar 11;294(11):578–582. doi: 10.1056/NEJM197603112941103. [DOI] [PubMed] [Google Scholar]
  13. JOSKE R. A., KING W. E. The L.E.-cell phenomenon in active chronic viral hepatitis. Lancet. 1955 Sep 3;269(6888):477–480. doi: 10.1016/s0140-6736(55)93331-6. [DOI] [PubMed] [Google Scholar]
  14. Jensen D. M., Hall C., Majewski T. The plasma membrane origin of liver-specific protein (LSP). Liver. 1983 Aug;3(4):213–219. doi: 10.1111/j.1600-0676.1983.tb00870.x. [DOI] [PubMed] [Google Scholar]
  15. Jensen D. M., McFarlane I. G., Portmann B. S., Eddleston A. L., Williams R. Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med. 1978 Jul 6;299(1):1–7. doi: 10.1056/NEJM197807062990101. [DOI] [PubMed] [Google Scholar]
  16. Kakumu S., Yata K., Kashio T. Immunoregulatory T-cell function in acute and chronic liver disease. Gastroenterology. 1980 Oct;79(4):613–619. [PubMed] [Google Scholar]
  17. Kashio T., Hotta R., Kakumu S. Lymphocyte suppressor cell activity in acute and chronic liver disease. Clin Exp Immunol. 1981 Jun;44(3):459–466. [PMC free article] [PubMed] [Google Scholar]
  18. Kirtland H. H., 3rd, Mohler D. N., Horwitz D. A. Methyldopa inhibition of suppressor-lymphocyte function: a proposed cause of autoimmune hemolytic anemia. N Engl J Med. 1980 Apr 10;302(15):825–832. doi: 10.1056/NEJM198004103021502. [DOI] [PubMed] [Google Scholar]
  19. Kojima M., Udo K., Takahashi Y., Yoshizawa H., Tsuda F., Itoh Y., Miyakawa Y., Mayumi M. Correlation between titer of antibody to hepatitis B core antigen and presence of viral antigens in the liver. Gastroenterology. 1977 Oct;73(4 Pt 1):664–667. [PubMed] [Google Scholar]
  20. Kronborg I. J., Evans D. T., Mackay I. R., Bhathal P. S. Chronic hepatitis after successive halothane anesthetics. Digestion. 1983;27(2):123–128. doi: 10.1159/000198941. [DOI] [PubMed] [Google Scholar]
  21. Laiwah A. A., Chaudhuri A. K., Anderson J. R. Lymphocyte transformation and leucocyte migration-inhibition by Australia antigen. Clin Exp Immunol. 1973 Sep;15(1):27–34. [PMC free article] [PubMed] [Google Scholar]
  22. Mackay I. R., Tait B. D. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology. 1980 Jul;79(1):95–98. [PubMed] [Google Scholar]
  23. Maddrey W. C., Boitnott J. K. Drug-induced chronic liver disease. Gastroenterology. 1977 Jun;72(6):1348–1353. [PubMed] [Google Scholar]
  24. Male D. K. Idiotypes and autoimmunity. Clin Exp Immunol. 1986 Jul;65(1):1–9. [PMC free article] [PubMed] [Google Scholar]
  25. McDevitt H. O. The HLA system and its relation to disease. Hosp Pract (Off Ed) 1985 Jul 15;20(7):57–72. doi: 10.1080/21548331.1985.11703093. [DOI] [PubMed] [Google Scholar]
  26. McFarlane B. M., McSorley C. G., Vergani D., McFarlane I. G., Williams R. Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol. 1986;3(2):196–205. doi: 10.1016/s0168-8278(86)80026-5. [DOI] [PubMed] [Google Scholar]
  27. McFarlane I. G. Autoimmunity in liver disease. Clin Sci (Lond) 1984 Dec;67(6):569–578. doi: 10.1042/cs0670569. [DOI] [PubMed] [Google Scholar]
  28. McFarlane I. G., McFarlane B. M., Major G. N., Tolley P., Williams R. Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin Exp Immunol. 1984 Feb;55(2):347–354. [PMC free article] [PubMed] [Google Scholar]
  29. Mieli-Vergani G., Vergani D., Portmann B., White Y., Murray-Lyon I., Marigold J. H., Woolf I., Eddleston A. L., Williams R. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease. Gut. 1982 Dec;23(12):1029–1036. doi: 10.1136/gut.23.12.1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Miller J., Smith M. G., Mitchell C. G., Reed W. D., Eddleston A. L., Williams R. Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet. 1972 Aug 12;2(7772):296–297. doi: 10.1016/s0140-6736(72)92904-2. [DOI] [PubMed] [Google Scholar]
  31. Mondelli M., Eddleston A. L. Mechanisms of liver cell injury in acute and chronic hepatitis B. Semin Liver Dis. 1984 Feb;4(1):47–58. doi: 10.1055/s-2008-1040645. [DOI] [PubMed] [Google Scholar]
  32. Mondelli M., Vergani G. M., Alberti A., Vergani D., Portmann B., Eddleston A. L., Williams R. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol. 1982 Dec;129(6):2773–2778. [PubMed] [Google Scholar]
  33. Montano L., Miescher G. C., Goodall A. H., Wiedmann K. H., Janossy G., Thomas H. C. Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection. Hepatology. 1982 Sep-Oct;2(5):557–561. doi: 10.1002/hep.1840020508. [DOI] [PubMed] [Google Scholar]
  34. Montaño L., Aranguibel F., Boffill M., Goodall A. H., Janossy G., Thomas H. C. An analysis of the composition of the inflammatory infiltrate in autoimmune and hepatitis B virus-induced chronic liver disease. Hepatology. 1983 May-Jun;3(3):292–296. doi: 10.1002/hep.1840030303. [DOI] [PubMed] [Google Scholar]
  35. Naumov N. V., Mondelli M., Alexander G. J., Tedder R. S., Eddleston A. L., Williams R. Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection. Hepatology. 1984 Jan-Feb;4(1):63–68. doi: 10.1002/hep.1840040111. [DOI] [PubMed] [Google Scholar]
  36. Neuberger J., Kenna J. G. Halothane hepatitis: a model of immune mediated drug hepatotoxicity. Clin Sci (Lond) 1987 Mar;72(3):263–270. doi: 10.1042/cs0720263. [DOI] [PubMed] [Google Scholar]
  37. Nouri-Aria K. T., Donaldson P. T., Hegarty J. E., Eddleston A. L., Williams R. HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitis. J Hepatol. 1985;1(3):235–241. doi: 10.1016/s0168-8278(85)80051-9. [DOI] [PubMed] [Google Scholar]
  38. Nouri-Aria K. T., Hegarty J. E., Alexander G. J., Eddleston A. L., Williams R. Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis. N Engl J Med. 1982 Nov 18;307(21):1301–1304. doi: 10.1056/NEJM198211183072102. [DOI] [PubMed] [Google Scholar]
  39. O'Brien C. J., Vento S., Donaldson P. T., McSorley C. G., McFarlane I. G., Williams R., Eddleston A. L. Cell-mediated immunity and suppressor-T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitis. Lancet. 1986 Feb 15;1(8477):350–353. doi: 10.1016/s0140-6736(86)92318-4. [DOI] [PubMed] [Google Scholar]
  40. Odièvre M., Maggiore G., Homberg J. C., Saadoun F., Couroucé A. M., Yvart J., Hadchouel M., Alagille D. Seroimmunologic classification of chronic hepatitis in 57 children. Hepatology. 1983 May-Jun;3(3):407–409. doi: 10.1002/hep.1840030320. [DOI] [PubMed] [Google Scholar]
  41. Ortona L., Laghi V., Cauda R., Nervo P. Lymphocyte transformation test with rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis. Clin Exp Immunol. 1979 Nov;38(2):231–234. [PMC free article] [PubMed] [Google Scholar]
  42. Pape G. R., Rieber E. P., Eisenburg J., Hoffmann R., Balch C. M., Paumgartner G., Riethmüller G. Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases. Gastroenterology. 1983 Sep;85(3):657–662. [PubMed] [Google Scholar]
  43. Realdi G., Alberti A., Rugge M., Bortolotti F., Rigoli A. M., Tremolada F., Ruol A. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology. 1980 Aug;79(2):195–199. [PubMed] [Google Scholar]
  44. SAINT E. G., KING W. E., JOSKE R. A., FINCKH E. S. The course of infectious hepatitis with special reference to prognosis and the chronic stage. Australas Ann Med. 1953 Nov;2(2):113–127. doi: 10.1111/imj.1953.2.2.113. [DOI] [PubMed] [Google Scholar]
  45. Sharp J. R., Ishak K. G., Zimmerman H. J. Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Ann Intern Med. 1980 Jan;92(1):14–19. doi: 10.7326/0003-4819-92-1-14. [DOI] [PubMed] [Google Scholar]
  46. Shoenfeld Y., Schwartz R. S. Immunologic and genetic factors in autoimmune diseases. N Engl J Med. 1984 Oct 18;311(16):1019–1029. doi: 10.1056/NEJM198410183111605. [DOI] [PubMed] [Google Scholar]
  47. Tage-Jensen U., Arnold W., Dietrichson O., Hardt F., Hopf U., Meyer Zum Büschenfelde K. H., Nielsen J. O. Liver-cell-membrane autoantibody specific for inflammatory liver diseases. Br Med J. 1977 Jan 22;1(6055):206–208. doi: 10.1136/bmj.1.6055.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Thestrup-Pedersen K., Ladefoged K., Andersen P. Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease. Clin Exp Immunol. 1976 Apr;24(1):1–8. [PMC free article] [PubMed] [Google Scholar]
  49. Thomas F. B. Chronic aggressive hepatitis induced by halothane. Ann Intern Med. 1974 Oct;81(4):487–489. doi: 10.7326/0003-4819-81-4-487. [DOI] [PubMed] [Google Scholar]
  50. Thomson A. D., Cochrane M. A., McFarlane I. G., Eddleston A. L., Williams R. Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis. Nature. 1974 Dec 20;252(5485):721–722. doi: 10.1038/252721a0. [DOI] [PubMed] [Google Scholar]
  51. Tong M. J., Wallace A. M., Peters R. L., Reynolds T. B. Lymphocyte stimulation in hepatitis B infections. N Engl J Med. 1975 Aug 14;293(7):318–322. doi: 10.1056/NEJM197508142930702. [DOI] [PubMed] [Google Scholar]
  52. Trevisan A., Realdi G., Alberti A., Ongaro G., Pornaro E., Meliconi R. Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B. Gastroenterology. 1982 Feb;82(2):218–222. [PubMed] [Google Scholar]
  53. Tsubouchi A., Yoshioka K., Kakumu S. Naturally occurring serum antiidiotypic antibody against antiliver-specific membrane lipoprotein in patients with hepatitis. Hepatology. 1985 Sep-Oct;5(5):752–757. doi: 10.1002/hep.1840050508. [DOI] [PubMed] [Google Scholar]
  54. Vento S., Hegarty J. E., Alberti A., O'Brien C. J., Alexander G. J., Eddleston A. L., Williams R. T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology. 1985 Mar-Apr;5(2):192–197. doi: 10.1002/hep.1840050206. [DOI] [PubMed] [Google Scholar]
  55. Vento S., Hegarty J. E., Bottazzo G., Macchia E., Williams R., Eddleston A. L. Antigen specific suppressor cell function in autoimmune chronic active hepatitis. Lancet. 1984 Jun 2;1(8388):1200–1204. doi: 10.1016/s0140-6736(84)91691-x. [DOI] [PubMed] [Google Scholar]
  56. Vento S., O'Brien C. J., McFarlane B. M., McFarlane I. G., Eddleston A. L., Williams R. T-lymphocyte sensitization to hepatocyte antigens in autoimmune chronic active hepatitis and primary biliary cirrhosis. Evidence for different underlying mechanisms and different antigenic determinants as targets. Gastroenterology. 1986 Oct;91(4):810–817. doi: 10.1016/0016-5085(86)90680-3. [DOI] [PubMed] [Google Scholar]
  57. Vergani D., Mieli-Vergani G., Alberti A., Neuberger J., Eddleston A. L., Davis M., Williams R. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med. 1980 Jul 10;303(2):66–71. doi: 10.1056/NEJM198007103030202. [DOI] [PubMed] [Google Scholar]
  58. Vergani G. M., Vergani D., Jenkins P. J., Portmann B., Mowat A. P., Eddleston A. L., Williams R. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Clin Exp Immunol. 1979 Oct;38(1):16–21. [PMC free article] [PubMed] [Google Scholar]
  59. Whittingham S., Mathews J. D., Schanfield M. S., Tait B. D., Mackay I. R. Interaction of HLA and Gm in autoimmune chronic active hepatitis. Clin Exp Immunol. 1981 Jan;43(1):80–86. [PMC free article] [PubMed] [Google Scholar]
  60. Zimmerman H. J. Drug-induced chronic hepatic disease. Med Clin North Am. 1979 May;63(3):567–582. doi: 10.1016/s0025-7125(16)31688-1. [DOI] [PubMed] [Google Scholar]
  61. Zinkernagel R. M., Doherty P. C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature. 1974 Apr 19;248(5450):701–702. doi: 10.1038/248701a0. [DOI] [PubMed] [Google Scholar]
  62. de Moura M. C., Vernace S. J., Paronetto F. Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases. Gastroenterology. 1975 Aug;69(2):310–317. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES